Genetic variants of the HLA-A, HLA-B and AIF1 loci show independent associations with type 1 diabetes in Norwegian families

Genes and Immunity

Volumn 10, Issue 2, 2009, Pages 141-150

  Eike, M C ^a,b   Olsson, M ^c   Undlien, D E ^d   Dahl Jorgensen K ^d,e   Joner, G ^b,d   Ronningen K S ^f   Thorsby, E ^a,b   Lie, B A ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

^f NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; HLA A ANTIGEN; HLA B ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; CONTROLLED STUDY; FAMILY STUDY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; NORWAY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 61849185778     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2008.88     Document Type: Article

References (54)

1. Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008; 57: 1084-1092.
2. Thomson G, Valdes AM, Noble JA, Kockum I, Grote MN, Najman J et al. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: A meta-analysis. Tissue Antigens 2007; 70: 110-127.
3. Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, Stevens HE et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007; 450: 887-892.
4. Aly TA, Baschal EE, Jahromi MM, Fernando MS, Babu SR, Fingerlin TE et al. Analysis of SNPs identifies major type 1A diabetes locus telomeric of the MHC. Diabetes 2008; 57: 770-776.
5. Nejentsev S, Reijonen H, Adojaan B, Kovalchuk L, Sochnevs A, Schwartz EI et al. The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes 1997; 46: 1888-1892.
6. Valdes AM, Erlich HA, Noble JA. Human leukocyte antigen class I B and C loci contribute to type 1 diabetes (T1D) susceptibility and age at T1D onset. Hum Immunol 2005; 66: 301-313.
7. Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR et al. Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci USA 2006; 103: 14074-14079.
8. Cheong KY, Allcock RJ, Eerligh P, Witt CS, Christiansen FT, McCann V et al. Localization of central MHC genes influencing type I diabetes. Hum Immunol 2001; 62: 1363-1370.
9. Lie BA, Todd JA, Pociot F, Nerup J, Akselsen HE, Joner G et al. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet 1999; 64: 793-800.
10. Nejentsev S, Gombos Z, Laine AP, Veijola R, Knip M, Simell O et al. Non-class II HLA gene associated with type 1 diabetes maps to the 240-kb region near HLA-B. Diabetes 2000; 49: 2217-2221.
11. Johansson S, Lie BA, Todd JA, Pociot F, Nerup J, Cambon-Thomsen A et al. Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLADQB1, -DQA1 and -DRB1. Genes Immun 2003; 4: 46-53.
12. Zavattari P, Lampis R, Motzo C, Loddo M, Mulargia A, Whalen M et al. Conditional linkage disequilibrium analysis of a complex disease superlocus, IDDM1 in the HLA region, reveals the presence of independent modifying gene effects influencing the type 1 diabetes risk encoded by the major HLADQB1, -DRB1 disease loci. Hum Mol Genet 2001; 10 881-889.
13. Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK et al. Gene map of the extended human MHC. Nat Rev Genet 2004; 5: 889-899.
14. Becker KG, Simon RM, Bailey-Wilson JE, Freidlin B, Biddison WE, McFarland HF et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 1998; 95: 9979-9984.
15. Pearce SH, Merriman TR. Genetic progress towards the molecular basis of autoimmunity. Trends Mol Med 2006; 12: 90-98.
16. Allcock RJ, Windsor L, Gut IG, Kucharzak R, Sobre L, Lechner D et al. High-density SNP genotyping defines 17 distinct haplotypes of the TNF block in the Caucasian population: Implications for haplotype tagging. Hum Mutat 2004; 24: 517-525.
17. Thomson G, Barcellos LF, Valdes AM. Searching for additional disease loci in a genomic region. Adv Genet 2008; 60: 253-292.
18. Eike MC, Becker T, Humphreys K, Olsson M, Lie BA. Conditional analyses on the T1DGC MHC dataset: Novel associations with type 1 diabetes around HLA-G and confirmation of HLA-B. Genes Immun (advance online publication, 2 October 2008; doi:10.1038/gene.2008.74).
19. Noble JA, Martin A, Valdes AM, Lane JA, Galgani A, Petrone A et al. Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: Association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controls. Hum Immunol 2008; 69: 291-300.
20. Noble JA, Valdes AM, Bugawan TL, Apple RJ, Thomson G, Erlich HA. The HLA class I A locus affects susceptibility to type 1 diabetes. Hum Immunol 2002; 63: 657-664.
21. Tait BD, Colman PG, Morahan G, Marchinovska L, Dore E, Gellert S et al. HLA genes associated with autoimmunity and progression to disease in type 1 diabetes. Tissue Antigens 2003; 61: 146-153.
22. Nakanishi K, Kobayashi T, Murase T, Naruse T, Nose Y, Inoko H. Human leukocyte antigen-A24 and -DQA1*0301 in Japanese insulin-dependent diabetes mellitus: Independent contributions to susceptibility to the disease and additive contributions to acceleration of beta-cell destruction. J Clin Endocrinol Metab 1999; 84: 3721-3725.
23. Nakanishi K, Kobayashi T, Murase T, Nakatsuji T, Inoko H, Tsuji K et al. Association of HLA-A24 with complete beta-cell destruction in IDDM. Diabetes 1993; 42: 1086-1093.
24. Nakanishi K, Inoko H. Combination of HLA-A24, -DQA1*03, and -DR9 contributes to acute-onset and early complete betacell destruction in type 1 diabetes: Longitudinal study of residual beta-cell function. Diabetes 2006; 55: 1862-1868.
25. Tait BD, Harrison LC, Drummond BP, Stewart V, Varney MD, Honeyman MC. HLA antigens and age at diagnosis of insulin-dependent diabetes mellitus. Hum Immunol 1995; 42: 116-122.
26. Fujisawa T, Ikegami H, Kawaguchi Y, Yamato E, Takekawa K, Nakagawa Y et al. Class I HLA is associated with age-at-onset of IDDM, while class II HLA confers susceptibility to IDDM. Diabetologia 1995; 38: 1493-1495.
27. Valdes AM, Thomson G, Erlich HA, Noble JA. Association between type 1 diabetes age of onset and HLA among sibling pairs. Diabetes 1999; 48: 1658-1661.
28. de Jersey J, Snelgrove SL, Palmer SE, Teteris SA, Mullbacher A, Miller JF et al. Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice. Proc Natl Acad Sci USA 2007; 104: 1295-1300.
29. Kay TW, Parker JL, Stephens LA, Thomas HE, Allison J. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice. J Immunol 1996; 157: 3688-3693.
30. Utsugi T, Yoon JW, Park BJ, Imamura M, Averill N, Kawazu S et al. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo. Diabetes 1996; 45: 1121-1131.
31. Sumida T, Furukawa M, Sakamoto A, Namekawa T, Maeda T, Zijlstra M et al. Prevention of insulitis and diabetes in beta 2-microglobulin-deficient non-obese diabetic mice. Int Immunol 1994; 6: 1445-1449.
32. Serreze DV, Leiter EH, Christianson GJ, Greiner D, Roopenian DC. Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes 1994; 43: 505-509.
33. Wicker LS, Leiter EH, Todd JA, Renjilian RJ, Peterson E, Fischer PA et al. Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 1994; 43: 500-504.
34. Brynedal B, Duvefelt K, Jonasdottir G, Roos IM, Akesson E, Palmgren J et al. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS ONE 2007; 2: E664.
35. Fogdell-Hahn A, Ligers A, Gronning M, Hillert J, Olerup O. Multiple sclerosis: A modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 2000; 55: 140-148.
36. Harbo HF, Lie BA, Sawcer S, Celius EG, Dai KZ, Oturai A et al. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 2004; 63: 237-247.
37. Zeggini E, Donn RP, Ollier WE, Thomson W. Evidence for linkage of HLA loci in juvenile idiopathic oligoarthritis: Independent effects of HLA-A and HLA-DRB1. Arthritis Rheum 2002; 46: 2716-2720.
38. Hall PJ, Burman SJ, Laurent MR, Briggs DC, Venning HE, Leak AM et al. Genetic susceptibility to early onset pauciarticular juvenile chronic arthritis: A study of HLA and complement markers in 158 British patients. Ann Rheum Dis 1986; 45: 464-474.
39. Rahman P. Genetics of ankylosing spondylitis: An update. Curr Rheumatol Rep 2007; 9: 383-389.
40. Smerdel-Ramoya A, Finholt C, Lilleby V, Gilboe IM, Harbo HF, Maslinski S et al. Systemic lupus erythematosus and the extended major histocompatibility complex - evidence for several predisposing loci. Rheumatology (Oxford) 2005; 44: 1368-1373.
41. Liu G, Ma H, Jiang L, Zhao Y. Allograft inflammatory factor-1 and its immune regulation. Autoimmunity 2007; 40: 95-102.
42. Chen ZW, Ahren B, Ostenson CG, Cintra A, Bergman T, Moller C et al. Identification, isolation, and characterization of daintain (allograft inflammatory factor 1), a macrophage polypeptide with effects on insulin secretion and abundantly present in the pancreas of prediabetic BB rats. Proc Natl Acad Sci USA 1997; 94: 13879-13884.
43. Kimura M, Kawahito Y, Obayashi H, Ohta M, Hara H, Adachi T et al. A critical role for allograft inflammatory factor-1 in the pathogenesis of rheumatoid arthritis. J Immunol 2007; 178: 3316-3322.
44. Noble JA, Valdes AM, Lane JA, Green AE, Erlich HA. Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility. Hum Immunol 2006; 67: 999-1004.
45. Morgan AW, Haroon-Rashid L, Martin SG, Gooi HC, Worthington J, Thomson W et al. The shared epitope hypothesis in rheumatoid arthritis: evaluation of alternative classification criteria in a large UK Caucasian cohort. Arthritis Rheum 2008; 58: 1275-1283.
46. Bjørnvold M, Undlien DE, Joner G, Dahl-Jørgensen K, Njølstad PR, Akselsen HE et al. Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes. Diabetologia 2008; 51: 589-596.
47. EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study Group. Lancet 2000; 355 873-876.
48. Cervin C, Lyssenko V, Bakhtadze E, Lindholm E, Nilsson P, Tuomi T et al. Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes 2008; 57: 1433-1437.
49. O'Connell JR, Weeks DE. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63: 259-266.
50. Wigginton JE, Abecasis GR. PEDSTATS: Descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 2005; 21: 3445-3447.
51. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003; 25: 115-121.
52. Cordell HJ, Clayton DG. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: Application to HLA in type 1 diabetes. Am J Hum Genet 2002; 70: 124-141.
53. Abecasis GR, Cookson WO. GOLD - graphical overview of linkage disequilibrium. Bioinformatics 2000; 16: 182-183.
54. Becker T, Knapp M. Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genet Epidemiol 2004; 27: 21-32.